Intellectus Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
1,598
+4
+0.3% +$1.11K 0.06% 237
2026
Q1
$471K Buy
1,594
+14
+0.9% +$4.16K 0.1% 208
2025
Q4
$432K Sell
1,580
-189
-11% -$51.4K 0.08% 204
2025
Q3
$478K Buy
1,769
+3
+0.2% +$816 0.09% 201
2025
Q2
$487K Sell
1,766
-48
-3% -$13.1K 0.11% 195
2025
Q1
$481K Buy
1,814
+16
+0.9% +$3.95K 0.12% 187
2024
Q4
$428K Buy
1,798
+2
+0.1% +$460 0.09% 204
2024
Q3
$396K Buy
+1,796
New +$372K 0.1% 198

Other funds holding CME

Intellectus Partners's CME Position: Q2 2026 in Review

Intellectus Partners increased its CME Group (CME) stake by 0.25% in Q2 2026, buying an estimated $1.11K and bringing the position to 1,598 shares worth $353K. The position accounts for 0.06% of the portfolio, ranked #237.

Intellectus Partners first reported a position in CME in Q3 2024 and has held it in 8 quarters since. The position peaked at $487K in Q2 2025. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Intellectus Partners held 1,598 shares of CME Group worth $353K as of Q2 2026.
  • Intellectus Partners bought 4 CME Group shares in Q2 2026, an estimated $1.11K.
  • CME Group made up 0.06% of Intellectus Partners's portfolio in Q2 2026, its #237 holding.
  • Intellectus Partners first reported a position in CME Group in Q3 2024 and has held it in 8 quarters since.
  • Intellectus Partners's CME Group position peaked at $487K in Q2 2025.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.